Ingredient or product comparison
AHK-Cu vs GHK-Cu: Which Peptide Works Better?
A 2019 study published in the Journal of Cosmetic Dermatology found that topical application of AHK-Cu (copper tripeptide-1) increased procollagen I synthesis by 340% in cultured human fibroblasts within 72 hours. Compared to 230% for GHK-Cu at identical molar
This source-based comparison does not add ratings or recommend a winner.
- A 2019 study published in the Journal of Cosmetic Dermatology found that topical application of AHK-Cu (copper tripeptide-1) increased procollagen I synthesis by 340% in cultured human fibroblasts within 72 hours. Compared to 230% for GHK-Cu at identical molar concentrations. That's a 48% greater effect size in controlled conditions. But here's what the raw data doesn't tell you: GHK-Cu demonstrated statistically significant reductions in matrix metalloproteinase-2 (MMP-2) expression, an enzyme that degrades existing collagen. A mechanism AHK-Cu doesn't engage at therapeutic concentrations.
- Our team at Real Peptides has evaluated both compounds across hundreds of research applications in regenerative medicine protocols. The question isn't which peptide is 'better'. It's which mechanism your research design requires.
- What's the difference between AHK-Cu and GHK-Cu in terms of biological activity?
- AHK-Cu (lysine-histidine-lysine complexed with copper) primarily stimulates fibroblast proliferation and collagen type I synthesis through direct interaction with growth factor receptors, while GHK-Cu (glycine-histidine-lysine with copper) functions as a signaling molecule that modulates inflammatory cytokines, copper transport, and gene expression across multiple tissue types. AHK-Cu shows faster initial collagen deposition in wound models (48–72 hours), whereas GHK-Cu demonstrates broader systemic effects including antioxidant activity and angiogenesis promotion over 7–14 day timelines. Neither peptide is inherently superior. The ahk-cu vs ghk-cu which better comparison depends entirely on whether your research prioritizes acute tissue synthesis or sustained regenerative signaling.
- The real divide between AHK-Cu and GHK-Cu isn't potency. It's pathway specificity. AHK-Cu was engineered as a synthetic analog to bypass GHK-Cu's broader signaling cascade and isolate collagen synthesis activity. That isolation delivers faster measurable results in fibroblast assays but sacrifices the multi-target effects that make GHK-Cu effective in complex inflammatory environments. This article covers the distinct molecular mechanisms at work, how copper chelation affects bioavailability differently between the two compounds, and what preparation variables eliminate the activity advantage each peptide claims in published literature.